Literature DB >> 30171260

BMP6-induced modulation of the tumor micro-milieu.

David Stieglitz1, Susanne Lamm1, Simone Braig2, Lena Feuerer1, Silke Kuphal1, Peter Dietrich1, Stephanie Arndt3, Bernd Echtenacher4, Claus Hellerbrand1,5, Sigrid Karrer3, Anja-Katrin Bosserhoff6,7.   

Abstract

Melanoma is the deadliest form of skin cancer with rising incidence, creating a significant health problem. We discovered increased expression of bone morphogenetic protein 6 (BMP6) in melanoma cells and tissues, and observed that BMP6 deficiency caused significantly delayed tumor onset and decelerated tumor progression in a melanoma mouse model. Moreover, we determined that BMP6 inhibits dermal mast cell recruitment and found that mast cell-derived mediators significantly reduced melanoma growth in vitro. In line with this, mast cell deficiency accelerated tumor onset and progression in a melanoma mouse model. Analysis of human melanoma tissues revealed a strong negative correlation between melanoma proliferation and mast cell infiltration. This study elucidates a novel role of BMP6-induced modulation of the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30171260     DOI: 10.1038/s41388-018-0475-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.

Authors:  Anja Katrin Bosserhoff; Lisa Ellmann; Silke Kuphal
Journal:  Exp Dermatol       Date:  2011-05       Impact factor: 3.960

2.  Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity.

Authors:  Thorsten B Feyerabend; Anne Weiser; Annette Tietz; Michael Stassen; Nicola Harris; Manfred Kopf; Peter Radermacher; Peter Möller; Christophe Benoist; Diane Mathis; Hans Jörg Fehling; Hans-Reimer Rodewald
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

3.  Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.

Authors:  Nicholas A Forward; Suzanne J Furlong; Yongjun Yang; Tong-Jun Lin; David W Hoskin
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

4.  Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.

Authors:  Mei-Yu Hsu; Sherry A Rovinsky; Chiou-Yan Lai; Shadi Qasem; Xiaoming Liu; Joan How; John F Engelhardt; George F Murphy
Journal:  Lab Invest       Date:  2008-06-16       Impact factor: 5.662

5.  Curine inhibits mast cell-dependent responses in mice.

Authors:  Jaime Ribeiro-Filho; Fagner Carvalho Leite; Hermann Ferreira Costa; Andrea Surrage Calheiros; Rafael Carvalho Torres; Carolina Trindade de Azevedo; Marco Aurélio Martins; Celidarque da Silva Dias; Patrícia T Bozza; Márcia Regina Piuvezam
Journal:  J Ethnopharmacol       Date:  2014-06-23       Impact factor: 4.360

6.  Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo.

Authors:  Stephanie Arndt; Ulrike Maegdefrau; Christoph Dorn; Katharina Schardt; Claus Hellerbrand; Anja-Katrin Bosserhoff
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

7.  Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.

Authors:  Stephanie Arndt; Eva Wacker; Christoph Dorn; Andreas Koch; Michael Saugspier; Wolfgang E Thasler; Arndt Hartmann; Anja Katrin Bosserhoff; Claus Hellerbrand
Journal:  Gut       Date:  2014-07-10       Impact factor: 23.059

8.  Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies.

Authors:  R C Benyon; E Y Bissonnette; A D Befus
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

Review 9.  Histamine in cancer immunotherapy: a preclinical background.

Authors:  Kristoffer Hellstrand
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

10.  Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant melanoma cells.

Authors:  Corinna Anna Ott; Lisa Linck; Elisabeth Kremmer; Gunter Meister; Anja Katrin Bosserhoff
Journal:  Oncotarget       Date:  2016-09-20
View more
  10 in total

1.  Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.

Authors:  Miriam Martha de Jel; Mandy Schott; Susanne Lamm; Winfried Neuhuber; Silke Kuphal; Anja-Katrin Bosserhoff
Journal:  Oncogenesis       Date:  2019-10-07       Impact factor: 7.485

2.  Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun's Nuclear Translocation and Activity.

Authors:  Melanie Kappelmann-Fenzl; Silke Kuphal; Rosemarie Krupar; Dirk Schadendorf; Viktor Umansky; Lily Vardimon; Claus Hellerbrand; Anja-Katrin Bosserhoff
Journal:  Cancers (Basel)       Date:  2019-11-17       Impact factor: 6.639

3.  GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients.

Authors:  Ulrike Neckmann; Camilla Wolowczyk; Martina Hall; Eivind Almaas; Jiang Ren; Sen Zhao; Bjarne Johannessen; Rolf I Skotheim; Geir Bjørkøy; Peter Ten Dijke; Toril Holien
Journal:  Cell Commun Signal       Date:  2019-11-06       Impact factor: 5.712

4.  TAM-ing the CIA-Tumor-Associated Macrophages and Their Potential Role in Unintended Side Effects of Therapeutics for Cancer-Induced Anemia.

Authors:  Stefan Weiler; Manfred Nairz
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 5.  Mast Cells and Skin and Breast Cancers: A Complicated and Microenvironment-Dependent Role.

Authors:  Mark R Hanes; Carman A Giacomantonio; Jean S Marshall
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

Review 6.  Mast Cell-Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth.

Authors:  Deisy Segura-Villalobos; Itzel G Ramírez-Moreno; Magnolia Martínez-Aguilar; Alfredo Ibarra-Sánchez; J Omar Muñoz-Bello; Isabel Anaya-Rubio; Alejandro Padilla; Marina Macías-Silva; Marcela Lizano; Claudia González-Espinosa
Journal:  Cells       Date:  2022-01-20       Impact factor: 6.600

7.  Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression.

Authors:  Magdalena Śmiech; Paweł Leszczyński; Christopher Wardell; Piotr Poznański; Mariusz Pierzchała; Hiroaki Taniguchi
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

8.  Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma.

Authors:  Gongjun Wang; Baoning Ding; Libin Sun; Jing Guo; Shasha Wang; Wenqian Li; Yuqi Zhang; Jing Lv; Wensheng Qiu
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

9.  Protease Profile of Tumor-Associated Mast Cells in Melanoma.

Authors:  Dmitri Atiakshin; Andrey Kostin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

10.  Protective role of mouse mast cell tryptase Mcpt6 in melanoma.

Authors:  Mirjana Grujic; Lars Hellman; Ann-Marie Gustafson; Srinivas Akula; Fabio Rabelo Melo; Gunnar Pejler
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-19       Impact factor: 4.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.